A look back at this year’s highlights from the GlycoNet community, from growing partnerships to breakthroughs in glycomics—the study of complex sugar molecules.
Tag: cancer
New radiotracer could make breast cancer detection quicker, more accurate
GlycoNet researchers set to test new PET scan molecule in European clinical trials.
2024 Wrapped at GlycoNet
Celebrating accomplishments and progress over the past year in glycomics—the science of complex sugars.
Researchers devise a quicker, more efficient way to make life-saving molecules
Improved method for creating nucleoside analogues opens the door to discovering countless treatments for everything from cancer to viral diseases.
GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture
Twenty-one projects receive funding to develop new therapeutics, tools and solutions by uncovering the roles of biological sugars in health and disease.
Sugar-blocking technology “supercharges” antibodies to fight cancer
GlycoNet investigators have created a much faster and simpler method of producing therapeutic antibodies that could help target different types of cancer.
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.